NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#4E)

Company

CRESCENT BIOPHARMA, INC.

Filed

May 8, 2024

Accession Number

0001072613-24-000441